OVATIOTM CRT

6750 model CRT-D 		OVATIO CRT-D

Gets it Right...Right out of the Box 

 

BTOTM

Intelligent Therapy at a wide range of heart rates

The Brady Tachy Overlap - CRT during rest and excercise. CRT patients exercise too – to achieve prolonged exercise benefit, CRT patients need to be resynchronized at increased heart rates.

 “The sudden loss of CRT during exercise might prevent the patient from experiencing prolonged, and eventually, beneficial physical activity.”1

  • OVATIO™ CRT detects and treats the full spectrum of ventricular tachyarrhythmias with painless antitachycardia pacing (ATP) or shocks if needed.

  • OVATIO CRT treats slow as well as the fastest ventricular tachycardias (100 bpm to 255 bpm).

  

PARAD+TM

Reducing Inappropriate shocks

Conventional ICDs have been reported to deliver inappropriate shocks in up to 35% of patients.3

  • The OVATIO CRT features PARAD®+ (P and R Arrhythmia Detection), the most specific SVT discrimination software available today.

  • PARAD+ provides 94% overall specifi city with out of-the-box settings1 and has the lowest inappropriate shock rate reported so far, 5%.4

  • “The specificity on SR, ST and SVT calculated from data collected at all rates was 94%.”1

 

Designed for comfort

Size and Shape

  • The OVATIO CRT is the smallest CRT available worldwide (30 cc, 11 mm thin).

  • OVATIO CRT is shaped to offer ease of implantation and long-term patient comfort and acceptance.

 

 

Indications, contraindications, warnings and precautions


1. Auricchio, A., et al. Exercise Performance Following Cardiac Resynchronization Therapy In Patients With Heart Failure and Ventricular Conduction Delay. The American Journal of Cardiology, Vol. 89, January 15, 2002.

2. Sadoul N., Mletzko R., Anselme F., for the Slow VT Study Group Incidence and Clinical Relevance of Slow Ventricular Tachycardia in Implantable Cardioverter-Defi brillator Recipients: An International Multicenter Prospective Study. Circulation 2005; 112:946-53.

3. Long-term outcome of patients who receive implantable cardioverter defi brillators for stable ventricular tachycardia. Glikson M., et al. Jour. Cardiov. Electrophys. June 2004.

4. Anselme F., et al: Prevention of Inappropriate Shocks in ICD Recipients: A review of 10,000 Tachycardia Episodes. PACE, Vol. 30, January 2007, Supplement 1.

Refer to user’s manual furnished with the device for intended uses and relevant warnings, precautions, side effects, and contraindications. Refer to user’s manual furnished with the device for complete instructions for use.